To quantify APOE-dependent effects on the relationship between BP and post-ICH outcomes, we first explored associations between APOE ɛ4 and the composite post-ICH poor outcome endpoint (including recurrent ICH, small vessel ischaemic stroke, dementia, depression and gait impairment) within each hypertension severity category. This evidence concerns the gene APOE and major depressive disorder.